#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital myopathy Fungal infection Mantle cell lymphoma stage IV Pancreatic carcinoma Factor IX deficiency Cutaneous T-cell lymphoma refractory Fontan procedure Prophylaxis against transplant rejection Autoimmune hepatitis Thrombocytopenia Neuronal ceroid lipofuscinosis Pulmonary fibrosis Congenital hypotransferrinaemia Haematological malignancy C3 glomerulopathy More trials…

    Learn about Rare Diseases

    Cystic fibrosis Pleural mesothelioma malignant – Diagnostics Paroxysmal nocturnal haemoglobinuria – Diagnostics Glomerulonephritis membranoproliferative – Trials in Disease Lymphatic malformation – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Nodal marginal zone B-cell lymphoma – Life with Disease Synovial sarcoma recurrent – Treatment Urea cycle disorder – Life with Disease Alveolar rhabdomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rigosertib Sodium Elafibranor Ampicillin Prx005 SEVABERTINIB Efavirenz SODIUM DIHYDROGEN PHOSPHATE Quercus Ilex Allergen Extract Tolebrutinib ANUMIGILIMAB Propafenone Hydrochloride Xxb750 Methotrexate Disodium Bosutinib GOVORESTAT 534 Zanidatamab Brinzolamide Adezunap Ide397 More therapies…

    Learn about Your Condition

    Biliary tract disorder Cholestatic pruritus Metabolic disorder Infertility male Cachexia White matter lesion Affective disorder Cold urticaria BK virus infection Rectal cancer stage III Castleman's disease Complicated appendicitis Endolymphatic hydrops Vascular malformation Rabies More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Finland

  • Safety, Pharmacokinetics, and Exploratory Efficacy of BI 1015550 and Nerandomilast in Children and Adolescents Aged 2‑17 Years With Fibrosing Interstitial Lung Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    • NERANDOMILAST
    Belgium Czechia Denmark Finland France Germany +6
  • Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabozantinib
    Denmark Finland France Italy The Netherlands Poland +2
  • Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

    Recruiting

    4 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • LUNSEKIMIG
    Belgium Denmark Estonia Finland France Germany +7
  • Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azetukalner
    Finland Germany Poland Romania Slovakia Spain
  • Venetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Fludarabine Phosphate
    • Cytarabine
    Austria Belgium Czechia Denmark Finland France +8
  • Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Odm-212
    • Sotorasib
    • Gemcitabine
    Denmark Finland France Spain
1 2 3 … 89
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Cyclophosphamide Carboplatin Dexamethasone Sodium Chloride Vincristine Sulfate Etoposide Paclitaxel Doxorubicin Hydrochloride Rituximab Nivolumab Cytarabine Lenalidomide Docetaxel Cisplatin Venetoclax Methotrexate Prednisone Oxaliplatin Enzalutamide Ifosfamide Tocilizumab Prednisolone Paracetamol Azacitidine Acetylsalicylic Acid Dexamethasone Acetate Dostarlimab Capecitabine Fludarabine Phosphate Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Acute myeloid leukaemia recurrent Acute myeloid leukaemia refractory Acute myocardial infarction Acute respiratory distress syndrome Adenocarcinoma of colon Allogenic stem cell transplantation Alpha-1 antitrypsin deficiency Amyotrophic lateral sclerosis Analgesic therapy Anaplastic large cell lymphoma T- and null-cell types Aortic valve disease Appendicitis Arteriosclerosis Asthma Atrial fibrillation Atypical teratoid/rhabdoid tumour of CNS Autonomic nervous system imbalance Avian influenza B-cell lymphoma B-cell lymphoma recurrent B-cell lymphoma refractory B-cell small lymphocytic lymphoma B-cell type acute leukaemia Bacterial infection Benign prostatic hyperplasia Beta haemolytic streptococcal infection Bile duct cancer Bladder cancer Bone marrow failure Brain stem glioma Breast cancer Breast cancer metastatic Bronchiectasis Bronchiolitis Bronchopulmonary dysplasia Cardiac failure Cardiac sarcoidosis Cardiovascular disorder Central nervous system lymphoma Central nervous system melanoma Cerebrovascular accident Cerebrovascular accident prophylaxis Cervix carcinoma Cervix carcinoma recurrent Cholangiocarcinoma Cholangitis sclerosing Cholecystitis acute Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic left ventricular failure Chronic lymphocytic leukaemia Chronic myeloid leukaemia Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Clear cell renal cell carcinoma Coeliac disease Cognitive disorder Colitis ulcerative Colon cancer Colorectal cancer Colorectal cancer metastatic Conjunctivitis allergic Contraception Coronary artery disease Cough COVID-19 Craniocerebral injury Critical illness Crohn's disease Cytomegalovirus immunisation Delirium Dementia Dementia Alzheimer's type Dermatitis atopic Diabetic foot Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma refractory Diphtheria immunisation Ductal adenocarcinoma of pancreas Dupuytren's contracture Dyslipidaemia Ectopic pregnancy EGFR gene mutation Elderly Embolism venous Emphysema Encephalopathy neonatal End stage renal disease Endocarditis bacterial Endometrial adenocarcinoma Endometrial cancer Endometrial cancer metastatic Endometrial cancer recurrent Endometrial cancer stage III Endometrial cancer stage IV Endometriosis Eosinophilic oesophagitis Ependymoma Epileptic encephalopathy Epstein-Barr virus associated lymphoma Ewing's sarcoma Ewing's sarcoma metastatic Ewing's sarcoma recurrent Extra-osseous Ewing's sarcoma Extra-osseous Ewing's sarcoma metastatic Extra-osseous Ewing's sarcoma recurrent Fabry's disease Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Fibrodysplasia ossificans progressiva Follicle centre lymphoma follicular grade I, II - III Follicle centre lymphoma follicular grade I, II - III recurrent Follicular lymphoma Frostbite Gastric cancer Gastrointestinal carcinoma Gastrointestinal melanoma Gastrointestinal stromal tumour General anaesthesia Generalised anxiety disorder Generalised tonic-clonic seizure Glaucoma Haemorrhage Haemorrhagic stroke Head and neck cancer Hemiparesis Hepatocellular carcinoma HER2 positive breast cancer Herpes zoster Hidradenitis High-grade B-cell lymphoma Hip arthroplasty HIV infection Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Hot flush Human epidermal growth factor receptor negative Huntington's disease Hypercholesterolaemia Hyperchylomicronaemia Hyperkalaemia Hypertension Hypertriglyceridaemia Hypertrophic cardiomyopathy Hypophosphatasia Hysterectomy Idiopathic generalised epilepsy Idiopathic pulmonary fibrosis Immune-mediated myositis Infantile spasms Inflammatory myofibroblastic tumour Influenza Influenza immunisation Inguinal hernia Insomnia Intensive care Interstitial lung disease Intracranial aneurysm Ischaemic stroke Juvenile idiopathic arthritis K-ras gene mutation Kidney transplant rejection Labour pain Laryngeal leukoplakia Laryngitis Left ventricular dysfunction Liposarcoma Lung adenocarcinoma Lung transplant rejection Lyme disease Major depression Malignant glioma Malignant lymphoid neoplasm Malignant melanoma Malignant melanoma of eyelid Malignant melanoma stage III Malignant melanoma stage IV Malignant peritoneal neoplasm Mantle cell lymphoma Mantle cell lymphoma stage II Mantle cell lymphoma stage III Mantle cell lymphoma stage IV Marginal zone lymphoma Mechanical ventilation Medulloblastoma Melanoma recurrent Meningococcal immunisation Meningococcal infection Metabolic syndrome Metapneumovirus infection Metastases to lymph nodes Metastatic malignant melanoma Metastatic renal cell carcinoma Migraine Mitral valve disease Multiple sclerosis Multiple sclerosis relapse Myasthenia gravis Myelodysplastic syndrome Myelodysplastic syndrome transformation Myelodysplastic syndrome with excess blasts Myocardial infarction Myocarditis Narcolepsy Neonatal asphyxia Neoplasm Neoplasm malignant Nephrogenic anaemia Nephropathy Nervous system disorder Netherton's syndrome Neuralgia Neuroblastoma Neurodegenerative disorder Neurodermatitis Neuroendocrine carcinoma Neuromuscular blockade Neuromuscular scoliosis Neurosurgery Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage IV Noonan syndrome Normal tension glaucoma Obesity Ocular myasthenia Oesophageal atresia Oesophageal squamous cell carcinoma Osteoarthritis Osteochondrodysplasia Osteomyelitis Osteosarcoma Otitis media Ovarian cancer Ovarian cancer metastatic Ovarian cancer recurrent Ovarian cancer stage III Ovarian cancer stage IV Ovarian epithelial cancer recurrent Overweight Pancreatic carcinoma Pancreatic neuroendocrine tumour Papillary cystadenoma lymphomatosum Paraganglion neoplasm Partial seizures Peripheral arterial occlusive disease Pertussis immunisation Phaeochromocytoma Plasma cell myeloma Plasma cell myeloma refractory Pneumococcal immunisation Pneumococcal infection Pneumonia respiratory syncytial viral Polycystic ovarian syndrome Post procedural complication Pre-eclampsia Precursor B-lymphoblastic lymphoma recurrent Precursor B-lymphoblastic lymphoma refractory Precursor T-lymphoblastic lymphoma/leukaemia recurrent Precursor T-lymphoblastic lymphoma/leukaemia refractory Primary progressive multiple sclerosis Procedural pain Progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis Prostate cancer Prostate cancer metastatic Prostate cancer recurrent Proteinuria Psoriasis Psoriatic arthropathy Pulmonary arterial hypertension Pulmonary fibrosis Pyoderma gangrenosum Rectal cancer Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cancer Renal cancer metastatic Renal cell carcinoma Renal cell carcinoma stage IV Renal impairment Renal transplant Respiratory syncytial virus bronchiolitis Respiratory syncytial virus bronchitis Respiratory syncytial virus infection Retinal artery occlusion Reversible cerebral vasoconstriction syndrome Rhabdomyosarcoma Schizophrenia Secondary progressive multiple sclerosis Sedative therapy Severe myoclonic epilepsy of infancy Short stature Short-bowel syndrome Sickle cell anaemia Sickle cell disease Sinusitis Sjogren's syndrome Skin squamous cell carcinoma metastatic Skin squamous cell carcinoma recurrent Small cell lung cancer Small cell lung cancer limited stage Small cell lung cancer recurrent Small for dates baby Soft tissue necrosis Spinal muscular atrophy Squamous cell carcinoma of head and neck Status epilepticus Subdural haematoma Systemic lupus erythematosus Systemic scleroderma Testicular seminoma (pure) Testis cancer Tetanus immunisation Thrombosis prophylaxis Torticollis Transient ischaemic attack Tricuspid valve disease Triple negative breast cancer Turner's syndrome Type 1 diabetes mellitus Type 2 diabetes mellitus Type IIa hyperlipidaemia Urinary tract infection Vesicoureteric reflux VEXAS syndrome Viral infection Von Willebrand's disease Wheezing Yellow fever

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!